Literature DB >> 1747133

Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout.

G M McCarthy1, C R Barthelemy, J A Veum, R L Wortmann.   

Abstract

Ten years ago, we studied the clinical and radiographic manifestations of gout in 60 patients and described 3 patterns of disease. To determine the consequences of management over a 10-year period, we recently reassessed the 39 available patients of this population. We found that although reduced tophaceous deposition on physical examination correlated with normalization of the serum urate concentration, no correlation existed between radiographic changes and mean serum urate concentrations. Progression of gouty changes on radiography reflected progressive deformity on physical examination. We have described the radiographic changes that occurred in a well-characterized population of subjects with gout over 10 years and determined that serum urate concentrations alone may not provide an effective means of monitoring the progression of tophaceous disease in bone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747133     DOI: 10.1002/art.1780341203

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

Review 3.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

4.  Missed opportunity following diagnosis of gout.

Authors:  S O'Reilly; M Doherty
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

5.  An MRI assessment of chronic synovial-based inflammation in gout and its correlation with serum urate levels.

Authors:  John D Carter; Michelle Patelli; Scott R Anderson; Neelesh Prakash; Ernesto J Rodriquez; Helen Bateman; Ashley Sterrett; Joanne Valeriano; Louis R Ricca
Journal:  Clin Rheumatol       Date:  2014-05-07       Impact factor: 2.980

Review 6.  The advanced imaging of gouty tophi.

Authors:  Amilcare Gentili
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

Review 7.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

Review 8.  Management of gout in older adults: barriers to optimal control.

Authors:  Karl T Hoskison; Robert L Wortmann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 9.  Imaging of gout: findings and utility.

Authors:  Fernando Perez-Ruiz; Nicola Dalbeth; Aranzazu Urresola; Eugenio de Miguel; Naomi Schlesinger
Journal:  Arthritis Res Ther       Date:  2009-06-17       Impact factor: 5.156

10.  Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.

Authors:  F Perez-Ruiz; A Alonso-Ruiz; M Calabozo; A Herrero-Beites; G García-Erauskin; E Ruiz-Lucea
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.